28 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Jul 24
Interim Consolidated Financial Statements
8:35am
Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
At the 2024 American Society of Clinical Oncology
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Jul 24
Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
8:35am
Tumors
At the 2024 American Society of Clinical Oncology (ASCO) annual meeting, the Company presented Phase 1 data from Parts 1 and 2 of the clinical
6-K
EX-99.2
THTX
Theratechnologies Inc.
15 Apr 24
Notice of Annual Meeting of Shareholders
9:31am
talent, the Montreal General Hospital Foundation and the Molson Foundation, a family foundation dedicated to the betterment of Canadian society.
Mr
6-K
EX-99.1
THTX
Theratechnologies Inc.
15 Feb 24
Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
8:36am
of sudocetaxel zendusortide, as presented at the 2023 annual meeting of the American Society of Clinical Oncology. Details about the study design, participation
6-K
EX-99.2
6hn0j
12 Jul 23
Interim Consolidated Financial Statements
8:02am
6-K
EX-99.1
qgb1rdrpi hi
12 Jul 23
Theratechnologies Reports Second Quarter 2023
8:00am
6-K
EX-99.1
vk6 jh1hzzn1
2 Jun 23
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
1:02pm
6-K
EX-99.2
w3mq2s6gm4qce ktqp
13 Apr 23
Notice of Annual Meeting of Shareholders
8:01am
6-K
EX-99.2
0x2qska
14 Apr 22
Notice of Annual Meeting of Shareholders
4:23pm
40-F
EX-99.1
gyuuy0jertpgd8x7m
24 Feb 22
Annual report (Canada)
8:02am
6-K
EX-99.2
ivfx97k
13 Oct 21
Interim Consolidated Financial Statements
8:00am
6-K
EX-99.1
30hccq81 8uxixalfw0
13 Oct 21
Theratechnologies Reports Financial Results
7:44am
6-K
EX-99.2
wl8pyz5pltfo
15 Jul 21
Interim Consolidated Financial Statements
7:30am
6-K
EX-99.2
bzwgp6
16 Apr 21
Notice of Annual Meeting of Shareholders
4:00pm
40-F
EX-99.1
k162qy
25 Feb 21
Annual report (Canada)
8:31am
40FR12B
EX-99.66
x330ybxis yr1n
27 Sep 19
Initial registration of securities (Canada)
5:05pm
40FR12B
EX-99.38
3yyejb
27 Sep 19
Initial registration of securities (Canada)
5:05pm
40FR12B
EX-99.67
pincykv 0x
27 Sep 19
Initial registration of securities (Canada)
5:05pm
40FR12B
EX-99.32
rfa2qvsru as
27 Sep 19
Initial registration of securities (Canada)
5:05pm